FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017258111> ?p ?o ?g. }

• W2017258111 endingPage "2600" @default.
• W2017258111 startingPage "2592" @default.
• W2017258111 abstract "Combination chemotherapy and radiotherapy (RT) were administered to 73 adults with non-Hodgkin's lymphoma (NHL). Ten cycles of the following drugs were given: intravenous Adriamycin (doxorubicin) (25 mg/m2), cyclophosphamide (700 mg/m2) and vincristine (1.5 mg/m2) on day 1; arabinosylcytosine (100 mg/m2) and methotrexate (10 mg/m2) on days 3 to 5; and oral prednisone (60 mg/m2) on days 1 to 5. Radiotherapy was given to resistant or initially bulky disease (2000 rad). Patients were also randomized to receive pseudomonas vaccine or no immunotherapy. of 61 evaluable patients, 33 (54%) achieved a complete response (CR) and 18 (30%) a partial response (PR). Among 44 evaluable patients with diffuse histiocytic lymphoma (DHL), 22 (50%) had a CR, and 15 (34%) a PR. for 17 evaluable patients with nodular (4) and diffuse (11) mixed and poorly differentiated lymphocytic and diffuse “undifferentiated” (2) lymphomas, CR and PR rates were 65% and 18%, respectively. No statistically significant differences in response rate or duration and survival have been observed between the patients randomized to receive pseudomonas vaccine or no immunotherapy. Median follow-up time from start of treatment was 47.5 months. Median survival for all 73 patients (including inevaluables) and for 52 DHL patients was 30.7 months. Poor prognostic features influencing survival included: female sex (P = 0.003), poor response to therapy (CR versus PR; P = 0.001), prior chemotherapy, (P = 0.01) and high levels of lactic dehydrogenase (P = 0.001). It can be concluded that this combination of cycle and phase-active agents is of similar efficacy to other reported regimens in inducing major responses and that it has the potential to prolong disease-free survival. The analysis of prognostic factors has been used to dissect poor prognostic categories that might require different modalities of treatment." @default.
• W2017258111 created "2016-06-24" @default.
• W2017258111 creator A5006117950 @default.
• W2017258111 creator A5014561472 @default.
• W2017258111 creator A5019450311 @default.
• W2017258111 creator A5025381409 @default.
• W2017258111 creator A5026156548 @default.
• W2017258111 creator A5027829771 @default.
• W2017258111 creator A5031408449 @default.
• W2017258111 creator A5032744554 @default.
• W2017258111 creator A5064065248 @default.
• W2017258111 creator A5082097483 @default.
• W2017258111 creator A5087914424 @default.
• W2017258111 date "1984-06-15" @default.
• W2017258111 modified "2023-09-27" @default.
• W2017258111 title "NHL-3 protocol six-drug combination chemotherapy for non-hodgkin's lymphoma" @default.
• W2017258111 cites W1497943205 @default.
• W2017258111 cites W1965180444 @default.
• W2017258111 cites W1970356712 @default.
• W2017258111 cites W1972822547 @default.
• W2017258111 cites W1984433383 @default.
• W2017258111 cites W1988641962 @default.
• W2017258111 cites W1995586052 @default.
• W2017258111 cites W1998800527 @default.
• W2017258111 cites W2009816078 @default.
• W2017258111 cites W2016000559 @default.
• W2017258111 cites W2021989617 @default.
• W2017258111 cites W2039857946 @default.
• W2017258111 cites W2047385586 @default.
• W2017258111 cites W2071739541 @default.
• W2017258111 cites W2082948115 @default.
• W2017258111 cites W2090333948 @default.
• W2017258111 cites W2123862763 @default.
• W2017258111 cites W2147584787 @default.
• W2017258111 cites W2426946988 @default.
• W2017258111 cites W4293241248 @default.
• W2017258111 cites W4298434897 @default.
• W2017258111 doi "https://doi.org/10.1002/1097-0142(19840615)53:12<2592::aid-cncr2820531204>3.0.co;2-7" @default.
• W2017258111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6547072" @default.
• W2017258111 hasPublicationYear "1984" @default.
• W2017258111 type Work @default.
• W2017258111 sameAs 2017258111 @default.
• W2017258111 citedByCount "17" @default.
• W2017258111 crossrefType "journal-article" @default.
• W2017258111 hasAuthorship W2017258111A5006117950 @default.
• W2017258111 hasAuthorship W2017258111A5014561472 @default.
• W2017258111 hasAuthorship W2017258111A5019450311 @default.
• W2017258111 hasAuthorship W2017258111A5025381409 @default.
• W2017258111 hasAuthorship W2017258111A5026156548 @default.
• W2017258111 hasAuthorship W2017258111A5027829771 @default.
• W2017258111 hasAuthorship W2017258111A5031408449 @default.
• W2017258111 hasAuthorship W2017258111A5032744554 @default.
• W2017258111 hasAuthorship W2017258111A5064065248 @default.
• W2017258111 hasAuthorship W2017258111A5082097483 @default.
• W2017258111 hasAuthorship W2017258111A5087914424 @default.
• W2017258111 hasConcept C126322002 @default.
• W2017258111 hasConcept C141071460 @default.
• W2017258111 hasConcept C2776694085 @default.
• W2017258111 hasConcept C2776755627 @default.
• W2017258111 hasConcept C2778720950 @default.
• W2017258111 hasConcept C2779338263 @default.
• W2017258111 hasConcept C2779429289 @default.
• W2017258111 hasConcept C2781059491 @default.
• W2017258111 hasConcept C3019864225 @default.
• W2017258111 hasConcept C509974204 @default.
• W2017258111 hasConcept C71924100 @default.
• W2017258111 hasConcept C90924648 @default.
• W2017258111 hasConceptScore W2017258111C126322002 @default.
• W2017258111 hasConceptScore W2017258111C141071460 @default.
• W2017258111 hasConceptScore W2017258111C2776694085 @default.
• W2017258111 hasConceptScore W2017258111C2776755627 @default.
• W2017258111 hasConceptScore W2017258111C2778720950 @default.
• W2017258111 hasConceptScore W2017258111C2779338263 @default.
• W2017258111 hasConceptScore W2017258111C2779429289 @default.
• W2017258111 hasConceptScore W2017258111C2781059491 @default.
• W2017258111 hasConceptScore W2017258111C3019864225 @default.
• W2017258111 hasConceptScore W2017258111C509974204 @default.
• W2017258111 hasConceptScore W2017258111C71924100 @default.
• W2017258111 hasConceptScore W2017258111C90924648 @default.
• W2017258111 hasIssue "12" @default.
• W2017258111 hasLocation W20172581111 @default.
• W2017258111 hasLocation W20172581112 @default.
• W2017258111 hasOpenAccess W2017258111 @default.
• W2017258111 hasPrimaryLocation W20172581111 @default.
• W2017258111 hasRelatedWork W160156331 @default.
• W2017258111 hasRelatedWork W2008641803 @default.
• W2017258111 hasRelatedWork W2058531229 @default.
• W2017258111 hasRelatedWork W2060816095 @default.
• W2017258111 hasRelatedWork W2088576405 @default.
• W2017258111 hasRelatedWork W2178567417 @default.
• W2017258111 hasRelatedWork W2409957350 @default.
• W2017258111 hasRelatedWork W2411798091 @default.
• W2017258111 hasRelatedWork W2462855755 @default.
• W2017258111 hasRelatedWork W2467938374 @default.
• W2017258111 hasVolume "53" @default.
• W2017258111 isParatext "false" @default.
• W2017258111 isRetracted "false" @default.
• W2017258111 magId "2017258111" @default.

• next